← Back to headlines
PTC Therapeutics Receives Upgrade at Jefferies Due to Sephience
PTC Therapeutics has been upgraded by Jefferies analysts, citing positive developments related to its product Sephience as the reason for the improved rating.
27 May, 17:06 — 27 May, 17:06
Sources
Showing 1 of 1 sources
